TCRvβ8 chimeric antigen receptor natural killer cells exhibit potent preclinical activity against T-cell malignancies.

ABSTRACT:

SUBMITTER: He L 

PROVIDER: S-EPMC11343688 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature